Aralast 01
Aralast Kit
Product Images NDC 0944-2815
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aralast (NDC 0944-2815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aralast 02
Aralast 03
Aralast 04
This text describes a medication called Alpha-Proteinase Inhibitor, the brand name being Aralast NP. It comes in a single-dose vial, and is a lyophilized powder that needs to be reconstituted with the provided sterile water. The reconstituted solution is for intravenous use only and must be used within three hours of reconstitution. It contains 400mg of active Alpha-Proteinase Inhibitor, and other components including albumin, polyethylene glycol, polysorbate 80, and sodium. The medication is prepared from human plasma pools and may carry a risk for hepatitis and/or other diseases. The package inserts contain the necessary information on how to use this medication safely, and the physician and patient should discuss the risks and benefits of using this product. The medication must be stored at temperatures not exceeding 25°C. For further reference, visit the website provided.*
Principal Display Panel (0.5 gram Vial Label)
Principal Display Panel (25 mL Vial Label)
This is a prescription-only, single-dose container of 25 mL sterile water, intended for use in reconstituting another product. The container has an NDC number of 52919-014-12 and should only be used as directed. It should not be used for intravascular injection unless brought to isotonic level by adding a suitable solute. The unused portion should be discarded, and the container has lot and Bxp numbers for tracking purposes.*
Aralast 07
This is a description of the drug Aralast NP, 1 gram which contains Alpha-Proteinase Inhibitor (Human). It is a lyophilized powder that is solvent detergent treated and nanofiltered for intravenous use. The reconstituted product must be used within three hours of reconstitution and contains not less than 800 mg active alpha-proteinase inhibitor per 1.0 g vial. It does not contain preservatives but may contain the causative agents of hepatitis and other diseases. The product comes with a package insert and is for intravenous administration only. It should be discussed between the patient and physician to determine its risks and benefits. The product is stored at temperatures not to exceed 25°C (77°F) and should not be frozen. Aralast NP is a trademark of Baxalta Incorporated, and Shire and the Shire Logo are trademarks or registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates.*
Principal Display Panel (1 gram Vial Label)
Aralast 09
This is a description of a medical product with NDC 52919-011-04 identifier. It is a 50 ml sterile water for injection, which is meant for the reconstitution of an accompanying product. Users should proceed with caution and not use it for intravascular injection without making it approximately isotonic by the addition of a suitable solute. The container is for single-dose only, and the unused portion should be discarded. No information was provided as to what the accompanying product is for.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
